公立医院买方垄断对制药产业研发投入的影响 : 基于博弈模型的理论分析和实证检验
Alternative Title
The impact of public hospitals' monopsony power on China's R&D input to pharmaceutical industry
Document Type
Journal article
Source Publication
山东大学学报 (哲学社会科学版) = Journal of Shandong University (Philosophy and Social Sciences)
Publication Date
1-1-2012
Issue
6
First Page
47
Last Page
53
Keywords
研究开发, 买方垄断, 制药产业, R&D, Monopsony, Pharmaceutical Industry
Abstract
通过理论模型和计量检验,分析了医院在药品市场买方垄断地位对制药产业研发投入的影响作用。构建三阶段博弈模型,通过求解子博弈精炼纳什均衡证明了无论对于品牌药生产还是仿制药生产,打破医院买方垄断地位均有利于制药企业增强研发投入激励;并且当下游市场结构相同时,品牌药厂商比仿制药厂商更有激励从事工艺创新。面板数据计量检验证实了医院买方垄断格局与制药产业研发投入呈负相关关系。
Public hospitals have a monopsony on retail drug sales in China.With theoretical and empirical methods,this paper discusses the impact of public hospitals’ monopsony power on the R&D input to pharmaceutical industry.We try to model threestage games and the SPNEs indicate that public hospitals’ monoposony power in pharmaceutical market stifles pharmaceutical enterprises’ incentives to innovate,as to both brandname drugs and generic drugs.Facing same downstream market structure,the producer of brandname drugs has more incentive to innovate in process innovation than the one of generic drugs.We also examines the conclusion by using panel data.The findings of this paper provides a new perspective for the research on R&D activity of pharmaceutical industry.
Print ISSN
10019839
Language
Chinese (Simplified)
Recommended Citation
刘旭宁、臧旭恒、林平 (2012)。公立医院买方垄断对制药产业研发投入的影响 : 基于博弈模型的理论分析和实证检验 = The impact of public hospitals' monopsony power on China's R&D input to pharmaceutical industry。《山东大学学报 (哲学社会科学版) = Journal of Shandong University (Philosophy and Social Sciences)》，(6)，47-53。